RENATA logo

Renata PLC Stock Price

DSE:RENATA Community·৳51.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 37 Fair Values set on narratives written by author

RENATA Share Price Performance

৳446.00
-55.30 (-11.03%)
৳446.00
-55.30 (-11.03%)
Price ৳446.00

RENATA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet average dividend payer.

2 Risks
0 Rewards

Renata PLC Key Details

৳44.3b

Revenue

৳25.6b

Cost of Revenue

৳18.6b

Gross Profit

৳16.1b

Other Expenses

৳2.5b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
22.11
42.09%
5.73%
41.2%
View Full Analysis

About RENATA

Founded
1972
Employees
8366
CEO
Syed S. Kabir
WebsiteView website
www.renata-ltd.com

Renata PLC manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh. The company offers generic products, including amantadine, clindamycin, clindamycin, colchicine, dipyridamole, escitalopram, fludrocortisone acetate, hydrocortisone, prednisolone, propylthiouracil, sertraline hydrochloride, terbinafine, and topiramate tablet and capsules. It also offers specialty products, such as SHK-024, an antidepressant, and SHK 007, to reduce toxicity in pediatrics. In addition, it provides animal health products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993. Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.

Recent RENATA News & Updates

Recent updates

No updates